ASCO: Few Eligible Smokers Had CT Screen for Lung CA in 2016

Share this content:
ASCO: Few Eligible Smokers Had CT Screen for Lung CA in 2016
ASCO: Few Eligible Smokers Had CT Screen for Lung CA in 2016

THURSDAY, May 17, 2018 (HealthDay News) -- In 2016, only 1.9 percent of the 7.6 million eligible smokers were screened for lung cancer, according to a study presented at the annual meeting of the American Society of Clinical Oncology, held from June 1 to 5 in Chicago.

Danh Pham, M.D., from the James Graham Brown Cancer Center at the University of Louisville in Kentucky, and colleagues used data from the Lung Cancer Screening Registry (LCSR) in 2016 to obtain information on the total number of low-dose computed tomography screenings from all 1,796 accredited radiographic screening sites. Screening of eligible smokers was estimated using the 2015 National Health Interview Survey per U.S. Preventive Services Task Force criteria and compared with the reported screens from the LCSR 2016.

The researchers found that 1.9 percent of 7.6 million eligible smokers were screened in 2016. There was variation in the rates by region, from 1.0 percent in the West to 3.5 percent in the Northeast. Most eligible smokers were populated in the South, which had the most accredited screening sites; however, the screening rates in the South were among the lowest (1.6 percent). Smoking cessation was offered to about 85 percent of the screened current smokers.

"It is unclear if the screening deficit is due to low provider referral or perhaps patient psychological barriers from fear of diagnosis," Pham said in a statement. "Lung cancer is unique in that there may be stigma associated with screening."

The study was funded by the Bristol-Myers Squibb Foundation.

Press Release
More Information

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »